Qiagen and Lilly team up

|About: Qiagen N.V. (QGEN)|By:, SA News Editor

Qiagen (QGEN) and Eli Lilly (LLY) collaborate to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types. The agreement includes tests based on QGEN's multi-modal multi-analyte Modaplex analysis platform which can process multiple sample types and biomarkers in a single test.

This is the fourth collaboration between the two companies.